158 related articles for article (PubMed ID: 25478316)
21. Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia.
Vivancos M; Fanelli R; Besserer-Offroy É; Beaulieu S; Chartier M; Resua-Rojas M; Mona CE; Previti S; Rémond E; Longpré JM; Cavelier F; Sarret P
Behav Brain Res; 2021 May; 405():113189. PubMed ID: 33607165
[TBL] [Abstract][Full Text] [Related]
22. Neurotensin NTS
Steele FF; Whitehouse SC; Aday JS; Prus AJ
Brain Res; 2017 Mar; 1658():31-35. PubMed ID: 28089664
[TBL] [Abstract][Full Text] [Related]
23. Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compound.
Thomas JB; Giddings AM; Wiethe RW; Olepu S; Warner KR; Sarret P; Gendron L; Longpre JM; Zhang Y; Runyon SP; Gilmour BP
J Med Chem; 2014 Jun; 57(12):5318-32. PubMed ID: 24856674
[TBL] [Abstract][Full Text] [Related]
24. NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization.
Perron A; Sharif N; Sarret P; Stroh T; Beaudet A
Biochem Biophys Res Commun; 2007 Feb; 353(3):582-90. PubMed ID: 17188644
[TBL] [Abstract][Full Text] [Related]
25. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2.
Gendron L; Perron A; Payet MD; Gallo-Payet N; Sarret P; Beaudet A
Mol Pharmacol; 2004 Dec; 66(6):1421-30. PubMed ID: 15361549
[TBL] [Abstract][Full Text] [Related]
26. Encounter Complexes Between the N-terminal of Neurotensin with the Extracellular Loop 2 of the Neurotensin Receptor 1 Steer Neurotensin to the Orthosteric Binding Pocket.
Asadollahi K; Rajput S; Jameson GNL; Scott DJ; Gooley PR
J Mol Biol; 2023 Oct; 435(20):168244. PubMed ID: 37625583
[TBL] [Abstract][Full Text] [Related]
27. Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain.
Guillemette A; Dansereau MA; Beaudet N; Richelson E; Sarret P
Eur J Pain; 2012 Apr; 16(4):473-84. PubMed ID: 22396077
[TBL] [Abstract][Full Text] [Related]
28. Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2.
Thomas JB; Giddings AM; Olepu S; Wiethe RW; Harris DL; Narayanan S; Warner KR; Sarret P; Longpre JM; Runyon SP; Gilmour BP
Bioorg Med Chem Lett; 2015 Jan; 25(2):292-6. PubMed ID: 25499438
[TBL] [Abstract][Full Text] [Related]
29. Involvement of NTS2 receptors in stress-induced analgesia.
Lafrance M; Roussy G; Belleville K; Maeno H; Beaudet N; Wada K; Sarret P
Neuroscience; 2010 Mar; 166(2):639-52. PubMed ID: 20035838
[TBL] [Abstract][Full Text] [Related]
30. The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.
Smith KE; Boules M; Williams K; Fauq AH; Richelson E
Behav Brain Res; 2011 Oct; 224(2):344-9. PubMed ID: 21718721
[TBL] [Abstract][Full Text] [Related]
31. The amide linker in nonpeptide neurotensin receptor ligands plays a key role in calcium signaling at the neurotensin receptor type 2.
Thomas JB; Giddings AM; Olepu S; Wiethe RW; Warner KR; Sarret P; Longpre JM; Runyon SP; Gilmour BP
Bioorg Med Chem Lett; 2015; 25(10):2060-4. PubMed ID: 25881832
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis, and Biological Evaluation of the First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor 2.
Bodin S; Previti S; Jestin E; Vimont D; Ait-Arsa I; Lamare F; Rémond E; Hindié E; Cavelier F; Morgat C
ACS Omega; 2023 Feb; 8(7):6994-7004. PubMed ID: 36844603
[TBL] [Abstract][Full Text] [Related]
33. The roles of neurotensin and its analogues in pain.
Feng YP; Wang J; Dong YL; Wang YY; Li YQ
Curr Pharm Des; 2015; 21(7):840-8. PubMed ID: 25345606
[TBL] [Abstract][Full Text] [Related]
34. NT69L, a novel analgesic, shows synergy with morphine.
Boules M; Shaw A; Liang Y; Barbut D; Richelson E
Brain Res; 2009 Oct; 1294():22-8. PubMed ID: 19651107
[TBL] [Abstract][Full Text] [Related]
35. Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine.
Boules M; Johnston H; Tozy J; Smith K; Li Z; Richelson E
Behav Pharmacol; 2011 Sep; 22(5-6):573-81. PubMed ID: 21691202
[TBL] [Abstract][Full Text] [Related]
36. Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model.
Roussy G; Dansereau MA; Doré-Savard L; Belleville K; Beaudet N; Richelson E; Sarret P
J Neurochem; 2008 May; 105(4):1100-14. PubMed ID: 18182046
[TBL] [Abstract][Full Text] [Related]
37. Spinal NTS2 receptor activation reverses signs of neuropathic pain.
Tétreault P; Beaudet N; Perron A; Belleville K; René A; Cavelier F; Martinez J; Stroh T; Jacobi AM; Rose SD; Behlke MA; Sarret P
FASEB J; 2013 Sep; 27(9):3741-52. PubMed ID: 23756650
[TBL] [Abstract][Full Text] [Related]
38. The Administration of Levocabastine, a NTS2 Receptor Antagonist, Modifies Na(+), K(+)-ATPase Properties.
Gutnisky A; López Ordieres MG; Rodríguez de Lores Arnaiz G
Neurochem Res; 2016 Jun; 41(6):1274-80. PubMed ID: 26738992
[TBL] [Abstract][Full Text] [Related]
39. Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS
Fanelli R; Chastel A; Previti S; Hindié E; Vimont D; Zanotti-Fregonara P; Fernandez P; Garrigue P; Lamare F; Schollhammer R; Balasse L; Guillet B; Rémond E; Morgat C; Cavelier F
Bioconjug Chem; 2020 Oct; 31(10):2339-2349. PubMed ID: 32887526
[TBL] [Abstract][Full Text] [Related]
40. Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice.
Bredeloux P; Costentin J; Dubuc I
Behav Brain Res; 2006 Dec; 175(2):399-407. PubMed ID: 17074405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
